Pete Stavropoulos
Stock Analyst at Cantor Fitzgerald
(3.51)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
JSPR Jasper Therapeutics | Downgrades: Neutral | n/a | n/a | n/a | 5 | Jul 7, 2025 | |
DRUG Bright Minds Bioscie... | Assumes: Overweight | n/a | n/a | n/a | 1 | Jul 2, 2025 | |
VERA Vera Therapeutics | Maintains: Overweight | 107 100 | 21.62 | 362.53% | 8 | May 7, 2025 | |
VYGR Voyager Therapeutics | Reiterates: Overweight | n/a | n/a | n/a | 2 | Mar 12, 2025 | |
ARCT Arcturus Therapeutic... | Reiterates: Overweight | n/a | n/a | n/a | 6 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | n/a | n/a | n/a | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 9 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | n/a | n/a | n/a | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 | 6.71 | -25.48% | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 13 | 1.38 | 842.03% | 2 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 15 | 16.7 | -10.18% | 2 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 | 9.59 | -16.58% | 1 | Mar 20, 2023 |